- 2 Ergebnisse
Kleinster Preis: € 109,00, größter Preis: € 173,95, Mittelwert: € 141,48
1
Bestellen
bei Indigo.ca
(ca. € 173,95)
Bestellengesponserter Link

Cancer Pharmacogenetics - neues Buch

ISBN: 9780387691336

The field of pharmacogenetics has expanded rapidly over the past few years since the release of the working draft of the human genome project and the continuing efforts of the internation… Mehr…

Versandkosten:zzgl. Versandkosten
2
Bestellen
bei bol.com
€ 109,00
Bestellengesponserter Link

Springer-Verlag New York Inc.:

Cancer Pharmacogenetics - neues Buch

2008, ISBN: 9780387691336

The field of pharmacogenetics has expanded rapidly over the past few years since the release of the working draft of the human genome project and the continuing efforts of the internation… Mehr…

  - Nieuw, Vermoedelijk 4-6 weken Versandkosten:Vermoedelijk 4-6 weken, zzgl. Versandkosten bol.com

1Da einige Plattformen keine Versandkonditionen übermitteln und diese vom Lieferland, dem Einkaufspreis, dem Gewicht und der Größe des Artikels, einer möglichen Mitgliedschaft der Plattform, einer direkten Lieferung durch die Plattform oder über einen Drittanbieter (Marketplace), etc. abhängig sein können, ist es möglich, dass die von eurobuch angegebenen Versandkosten nicht mit denen der anbietenden Plattform übereinstimmen.

Bibliographische Daten des bestpassenden Buches

Details zum Buch

The field of pharmacogenetics has expanded rapidly over the past few years since the release of the working draft of the human genome project and the continuing efforts of the international HapMap project. Cancer therapy offers an ideal scenario for the integration of pharmacogenetics into clinical practice - often there are multiple treatment options but a finite window of time to select the correct one. The ideal of testing patients for genetic markers for chemotherapy efficacy and/or toxicity is becoming a reality with FDA approved clinical tests and genotype-guided clinical trials. This volume is designed to offer an overview of the role of pharmacogenetics in cancer treatment, from the history of the field through to its integration into clinical practice. TOC:A History of Pharmacogenetics.- Pharmacokinetics and pharmacogenetics.- drug targets and pharmacogenetics.- Pharmacodynamics and pharmacogenetics.- toxicity and pharmacogentics.- Leukemia: the TPMT Example.- Solid tumors I: The UGT1A1 Example.- Solid Tumors II: the EGFR Example.- Novel Pharmacogenetic markers: whole genome association studies.- In silico resources for cancer pharmacogenetics: databases and knowledge bases.- pharmacogenetics methodology-overview of available methods.- From bedside to clinical practice I: Clinical trials.- From Bedside to Clinical Practice II: FDA.- The Future of Cancer Pharmacogenetics

Detailangaben zum Buch - Cancer Pharmacogenetics


EAN (ISBN-13): 9780387691336
ISBN (ISBN-10): 0387691332
Erscheinungsjahr: 2008
Herausgeber: Springer

Buch in der Datenbank seit 2008-03-03T08:33:19+01:00 (Zurich)
Detailseite zuletzt geändert am 2017-02-01T21:28:53+01:00 (Zurich)
ISBN/EAN: 9780387691336

ISBN - alternative Schreibweisen:
0-387-69133-2, 978-0-387-69133-6
Alternative Schreibweisen und verwandte Suchbegriffe:
Titel des Buches: pharmacogenetics, cancer


Daten vom Verlag:

Autor/in: Sharon Marsh
Titel: Cancer Pharmacogenetics
Verlag: Springer; Springer US
280 Seiten
Erscheinungsjahr: 2010-06-15
New York; NY; US
Sprache: Englisch
112,30 € (DE)
115,45 € (AT)
150,65 CHF (CH)
Not available, publisher indicates OP

BB; Book; Hardcover, Softcover / Medizin/Nichtklinische Fächer; Onkologie; cancer therapy; genetics; chemotherapy; toxicity; cancer treatment; drug; leukemia; pharmacodynamics; research; pharmacokinetics; clinical trial; cancer; kinetics; B; Cancer Research; Biomedical and Life Sciences; Pharmacology/Toxicology; Health Promotion and Disease Prevention; Epidemiology; Medical Microbiology; Pharmakologie; Public Health und Präventivmedizin; Epidemiologie und medizinische Statistik; Mikrobiologie und Virologie; EA

A History of Pharmacogenetics.- Pharmacokinetics and pharmacogenetics.- drug targets and pharmacogenetics.- Pharmacodynamics and pharmacogenetics.- toxicity and pharmacogentics.- Leukemia: the TPMT Example.- Solid tumors I: The UGT1A1 Example.- Solid Tumors II: the EGFR Example.- Novel Pharmacogenetic markers: whole genome association studies.- In silico resources for cancer pharmacogenetics: databases and knowledge bases.- pharmacogenetics methodology-overview of available methods.- From bedside to clinical practice I: Clinical trials.- From Bedside to Clinical Practice II: FDA.- The Future of Cancer Pharmacogenetics
This volume is designed to offer an overview of the role of pharmacogenetics in cancer treatment, from the history of the field through to its integration into clinical practice.

< zum Archiv...